Quantum BioPharma Ltd.
General ticker "QNTM" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $43.6M (TTM average)
Quantum BioPharma Ltd. does not follow the US Stock Market performance with the rate: -26.9%.
Estimated limits based on current volatility of 4.0%: low 3.25$, high 3.52$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.63$, 5.66$]
- 2025-12-31 to 2026-12-31 estimated range: [1.19$, 3.95$]
Short-term QNTM quotes
Long-term QNTM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.43MM | $23.79MM | $16.14MM |
| Operating Income | $-27.43MM | $-23.79MM | $-16.14MM |
| Non-Operating Income | $0.73MM | $5.56MM | $1.22MM |
| Interest Expense | $0.05MM | $0.00MM | $0.05MM |
| R&D Expense | $6.91MM | $3.86MM | $6.08MM |
| Income(Loss) | $-26.70MM | $-18.23MM | $-14.92MM |
| Net Income(Loss)* | $-23.61MM | $-17.90MM | $-14.20MM |
| Stockholders Equity | $30.54MM | $13.24MM | $11.48MM |
| Inventory | $0.00MM | $0.00MM | $0.12MM |
| Assets | $38.41MM | $17.47MM | $17.12MM |
| Operating Cash Flow | $-28.33MM | $-10.83MM | $-6.88MM |
| Capital expenditure | $0.36MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $12.12MM | $-0.27MM | $-1.50MM |
| Financing Cash Flow | $-2.07MM | $-3.13MM | $11.62MM |
| Earnings Per Share** | $-39.62 | $-29.39 | $-12.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.